dr. ir. Laurentijn Tilleman
- ORCID iD
- 0000-0001-7584-1179
Show
Sort by
-
- Journal Article
- A1
- open access
Post-feeding transcriptomics reveals essential genes expressed in the midgut of the desert locust
-
- Journal Article
- A1
- open access
Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling
-
- Journal Article
- A1
- open access
Intrathymic dendritic cell-biased precursors promote human T cell lineage specification through IRF8-driven transmembrane TNF
-
Exploring and optimizing variant detection and phasing methods in pharmacogenomics
(2022) -
- Journal Article
- A1
- open access
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
-
- Journal Article
- A1
- open access
Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing
-
Cas9 targeted nanopore sequencing with enhanced variant calling improves CYP2D6-CYP2D7 hybrid allele genotyping
-
- Conference Paper
- C3
- open access
Phasing of the entire CYP2D6 locus with CRISPR-Cas9 enriched Nanopore sequencing
-
RRM2 enhances MYCN driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
-
Metallothioneins alter macrophage phenotype and represent novel therapeutic targets for acetaminophen-induced liver injury